Cargando…

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis

AIMS: We assessed the value of automated MRI quantification methods in the differential diagnosis of behavioral-variant frontotemporal dementia (bvFTD) from Alzheimer disease (AD), Lewy body dementia (LBD), and subjective memory complaints (SMC). We also examined the role of the C9ORF72-related gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cajanus, Antti, Hall, Anette, Koikkalainen, Juha, Solje, Eino, Tolonen, Antti, Urhemaa, Timo, Liu, Yawu, Haanpää, Ramona M., Hartikainen, Päivi, Helisalmi, Seppo, Korhonen, Ville, Rueckert, Daniel, Hasselbalch, Steen, Waldemar, Gunhild, Mecocci, Patrizia, Vanninen, Ritva, van Gils, Mark, Soininen, Hilkka, Lötjönen, Jyrki, Remes, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869565/ https://www.ncbi.nlm.nih.gov/pubmed/29606954 http://dx.doi.org/10.1159/000486849

Ejemplares similares

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia
por: Cajanus, Antti, et al.
Publicado: (2019)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Grey matter atrophy in patients with benign multiple sclerosis
por: Niiranen, Marja, et al.
Publicado: (2022)

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019)

Evaluating combinations of diagnostic tests to discriminate different dementia types
por: Bruun, Marie, et al.
Publicado: (2018)

Structural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor-Based Morphometry and Voxel-Based Morphometry
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2012)

Differential diagnosis of neurodegenerative diseases using structural MRI data
por: Koikkalainen, Juha, et al.
Publicado: (2016)

Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
por: Katisko, Kasper, et al.
Publicado: (2019)

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study
por: Bruun, Marie, et al.
Publicado: (2019)

Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
por: Tong, Tong, et al.
Publicado: (2017)

Detecting frontotemporal dementia syndromes using MRI biomarkers
por: Bruun, Marie, et al.
Publicado: (2019)

Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients
por: Jääskeläinen, Olli, et al.
Publicado: (2019)

Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2016)

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis
por: Cajanus, Antti, et al.
Publicado: (2020)

Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
por: Liu, Yawu, et al.
Publicado: (2013)

Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability
por: Koikkalainen, Juha, et al.
Publicado: (2012)

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier
por: Tolonen, Antti, et al.
Publicado: (2018)

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease
por: Jääskeläinen, Olli, et al.
Publicado: (2020)

Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
por: Wolz, Robin, et al.
Publicado: (2011)

Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
por: Pekkala, Timo, et al.
Publicado: (2020)

Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion
por: Katisko, Kasper, et al.
Publicado: (2019)

Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy
por: Rhodius-Meester, Hanneke F. M., et al.
Publicado: (2020)

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
por: Rostalski, Hannah, et al.
Publicado: (2019)

Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease
por: Orešič, Matej, et al.
Publicado: (2010)

Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
por: Stephen, Ruth, et al.
Publicado: (2019)

Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
por: Katisko, Kasper, et al.
Publicado: (2022)

Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment
por: Moreland, Jamie, et al.
Publicado: (2018)

Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
por: Rhodius‐Meester, Hanneke F.M., et al.
Publicado: (2020)

Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis
por: Stephen, Ruth, et al.
Publicado: (2021)

Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case
por: Korhonen, V. E., et al.
Publicado: (2017)

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches
por: Huber, Nadine, et al.
Publicado: (2021)

Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)

FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
por: Leskelä, Stina, et al.
Publicado: (2021)

Evaluating 2-[(18)F]FDG-PET in differential diagnosis of dementia using a data-driven decision model
por: Gjerum, Le, et al.
Publicado: (2020)

Diabetes is associated with familial idiopathic normal pressure hydrocephalus: a case–control comparison with family members
por: Räsänen, Joel, et al.
Publicado: (2020)

Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition
por: Stephen, Ruth, et al.
Publicado: (2017)

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
por: Giunta, Marcello, et al.
Publicado: (2021)

Global Burden of Small Vessel Disease–Related Brain Changes on MRI Predicts Cognitive and Functional Decline
por: Jokinen, Hanna, et al.
Publicado: (2020)

Copy number loss in SFMBT1 is common among Finnish and Norwegian patients with iNPH
por: Korhonen, Ville E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1c4mha43ufofr3po45td95v9qn